E-LIB Suche - Ergebnisse für: Lown, K.S.

1

Efavirenz induit spécifiquement le CYP3A4 hépatique et non ..:

Mouly, S. ; Lown, K.S. ; Wille, R.T....
La Revue de Médecine Interne. 23 (2002) - p. 608s , 2002

2

Cellular-Based Selections Aid Yeast-Display Discovery of Ge..:

Stern, Lawrence A. ; Lown, Patrick S. ; Kobe, Alexandra C....
ACS Combinatorial Science. 21 (2019) 3 - p. 207-222 , 2019

Link: https://doi.org/10.1021/..

3

Selective expression of CYP3A5 and not CYP3A4 in human bloo:

Janardan, Srinivas K. ; Lown, Kenneth S. ; Schmiedlin-Ren, Phyllissa..
Pharmacogenetics. 6 (1996) 5 - p. 379-385 , 1996

Link: https://doi.org/10.1097/..

4

Selective suppression of the cranial bone resonance from 31..:

Ackerman, Joseph J.H ; Evelhoch, Jeffrey L ; Berkowitz, Bruce A...
Journal of Magnetic Resonance (1969). 56 (1984) 2 - p. 318-322 , 1984

Link: https://doi.org/10.1016/..

5

Developing a multidisciplinary medication review and depres..:

Radcliffe, E ; Saucedo, A R ; Howard, C...
International Journal of Pharmacy Practice. 32 (2024) Supplement_1 - p. i25-i26 , 2024

Link: https://doi.org/10.1093/..

6

DNA Sequence Recognition of Thiazole-Containing Cross-Linke..:

Burckhardt, G. ; Simon, H. ; Birch-Hirschfeld, E....
Journal of Biomolecular Structure and Dynamics. 19 (2002) 6 - p. 1101-1109 , 2002

Link: https://doi.org/10.1080/..

7

Netropsin and bis-netropsin analogs as inhibitors of the ca..:

Beerman, T.A. ; Woynarowski, J.M. ; Sigmund, R.D....
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1090 (1991) 1 - p. 52-60 , 1991

Link: https://doi.org/10.1016/..

8

DNA Apurinic Sites: Synthesis of a Model Compound and Study..:

Vasseur, J.-J. ; Rayner, B. ; Imbach, J.-L....
Nucleosides and Nucleotides. 6 (1987) 1-2 - p. 467-468 , 1987

Link: https://doi.org/10.1080/..

9

Randomized controlled trial of molnupiravir SARS-CoV-2 vira..:

Standing, J.F ; Buggiotti, L ; Guerra-Assuncao, J.A...
https://eprints.whiterose.ac.uk/211947/1/s41467-024-45641-0.pdf. , 2024

Link: https://eprints.whiteros..

10

Immunogenicity of third dose COVID-19 vaccine strategies in..:

Goodyear, C.S ; Patel, A ; Barnes, E...
https://eprints.whiterose.ac.uk/212871/1/OCTAVE%20DUO%20Lancet%20Rheumatology%202024.pdf. , 2024

Link: https://eprints.whiteros..

11

Cost-utility analysis of molnupiravir plus usual care versu..:

Png, ME ; Harris, V ; Grabey, J...
https://www.ncbi.nlm.nih.gov/pubmed/38228357. , 2024

Link: http://hdl.handle.net/10..

12

Cost-utility analysis of molnupiravir plus usual care versu..:

Png, ME ; Harris, V ; Grabey, J...
doi:10.3399/BJGP.2023.0444. , 2024

Link: https://doi.org/10.3399/..

13

Platform adaptive trial of novel antivirals for early treat..:

Gbinigie, O ; Ogburn, E ; Allen, J...
doi:10.1136/bmjopen-2022-069176. , 2023

Link: https://doi.org/10.1136/..

14

Molnupiravir plus usual care versus usual care alone as ear..:

Butler, C ; Hobbs, FDR ; Gbinigie, O...
doi:10.2139/ssrn.4237902. , 2023

Link: https://doi.org/10.2139/..

15

Platform adaptive trial of novel antivirals for early treat..:

Gbinigie, O ; Ogburn, E ; Allen, J...
BMJ Open, 13(8). , 2023

Link: http://hdl.handle.net/10..